Printer Friendly
The Free Library
14,681,102 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Scott Wolf, M.D., Founder of Percardia, Cardiac Dimensions, Archus Orthopedics, to Give 'State of Medtech Investing - 2006' Presentation at Medtech Insight's 'In3 WEST' Conference.


NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif. -- "Investment In Innovation (In3) WEST: A Preview of Early-Stage Medical Technology Companies," Feb. 23-24, 2006, Irvine, Calif.

Medtech Insight has announced that Dr. Scott Wolf Scott Richard Wolf (born June 4, 1968) is an American actor.

Born in Boston, Massachusetts to Steven Wolf and Susan Enowitch, Wolf was raised in West Orange, New Jersey. He graduated in 1986 from West Orange High School.
, partner at Prospect Venture Partners and founder of Percardia, Cardiac Dimensions, Archus Orthopedics and Endogastric Solutions, will give the "State of Medtech Investing - 2006" keynote address keynote address
n.
An opening address, as at a political convention, that outlines the issues to be considered. Also called keynote speech.

Noun 1.
 at their upcoming "Investment In Innovation (In3) WEST: A Preview of Early-Stage Medical Technology Companies" conference, being held Feb. 23-24, 2006, at the Hyatt Regency Irvine in Irvine, Calif. The event, the company's 20th investment and partnering conference to date, will showcase 50 innovative, emerging startup companies from around the world developing diagnostic and therapeutic products in the hottest medical specialty medical specialty Any specialty that provides non-interventional Pt management, ie with drugs, or with minimum intervention–eg, balloon catheterization Examples Internal medicine–allergy and immunology, cardiology, gastroenterology, hematology/oncology,  areas. These companies will present to a focused audience of senior executives representing most of the major investment and medical technology firms, for purposes of funding and/or strategic partnership.

Prior to joining Prospect Venture Partners, Dr. Wolf was a vice president at Frazier Healthcare Ventures, where he was involved in medical device investments across all stages, from seed to commercialization. While at Frazier, he founded and served as CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  and director of Juniper Medical, a device startup developing non-invasive methods of bodysculpting and cellulite cel·lu·lite
n.
A fatty deposit causing a dimpled or uneven appearance, as around the thighs.


Cellulite
Cellulite is dimply skin caused by uneven fat deposits beneath the surface.
 therapy. Wolf was also a founding partner of Scout Medical Technologies, a venture capital medical device incubator company. While at Scout, he co-founded three portfolio companies: Cardiac Dimensions, Archus Orthopedics, and Endogastric Solutions. Prior to Scout, Wolf was president of Itasca Ventures, a device incubator funded by Medtronic. At Itasca, he founded Percardia, a device company developing a percutaneous therapy for coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. , and assisted in Medtronic's spinout spin·out  
n.
An instance of spinning out: a motorist who was injured in a spinout. 
 of TissueLink Inc. He is also an inventor on numerous issued and pending patents in the medical device field.

In3 WEST will include focused 10-minute presentations by a senior executive from each presenting company, followed immediately by one-on-one meetings with company representatives in private breakout rooms. The meeting will also feature tabletop exhibits and product prototypes by presenting companies during a networking dinner, an interactive industry panel discussion featuring top business development execs from a number of major device companies, and keynote presentations by respected industry and financial leaders.

Presenting companies confirmed thus far include (most presenting at a Medtech Insight event for the first time; many more being added): ACell, AerovectRx, AION AION Anterior Ischemic Optic Neuropathy  Diagnostics, Biosan Medical, Cardiovascular Systems, CLEVEX, CVAC CVAC Carolina-Virginia Athletic Conference
CVAC Cyclic Variations in Altitude Conditioning
CVAC Chappaqua Volunteer Ambulance Corps (Chappaqua, New York)
CVAC Consolidated Vultee Aircraft Corporation
 Systems, Cytograft Tissue Engineering, Design Medical, EndoCor, Gene Express, Gluco Stats System, InnerVision Medical Technologies, Lingualcare, MedicalCV, Novomedica, OtisMed, Paradigm Spine, PhotoImmune Biotechnology, Tekia, VasoGenix Pharmaceuticals, and Vision Solutions Technologies, among many others being confirmed regularly. See the Medtech Insight Web site for event details: http://www.medtechinsight.com/in3-16.html.

Medtech Insight's conferences have drawn over 5,600 attendees and over 630 innovative early-stage presenting companies over the past five years, making them the premier investment, partnering, and networking event in the medical technology industry. To register to attend or if your emerging company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., e-mail kristy@medtechinsight.com, or visit www.medtechinsight.com. Through Dec. 23, 2005, attendees registering for the conference can save $300 off the $1,495 registration fee.

About Medtech Insight

Medtech Insight, a division of Windhover wind·hov·er  
n. Chiefly British
A kestrel.
 Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, and to see the company's 2006 conference schedule, please visit www.medtechinsight.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 19, 2005
Words:576
Previous Article:Fitch Issues Presale on Aviation Capital Group Trust III Series 2005-1.
Next Article:The Beacon Council Unveils the Miami Business Profile & Relocation Guide 2006.
Topics:



Related Articles
Medtech Insight and Windhover Information Announce the 'In3 WEST' Early-Stage Medical Technology Investment and Partnering Conference, Feb. 23-24,...
Emerging Cardiovascular, Orthopedics/Spine, Stroke, Drug Delivery, Pharma, Diagnostics and Diabetes Companies Among the 50 Presenters at Medtech...
Medical Device Serial Entrepreneur Michael Henson, General Partner at MedFocus Fund, to Give Keynote Address at Medtech Insight's Upcoming Investment...
50 Innovative Emerging Medical Technology Companies Seeking Funding and/or Strategic Partnership to Present at Medtech Insight's 'In3 WEST'...
Nearly 30 Emerging Medical Device, Biomaterials, and Pharma Companies Confirmed to Date to Present at Medtech Insight's 'In3 WEST' Medical Technology...
40 Early-Stage Medical Technology Companies Confirmed to Date to Present at Medtech Insight's 'In3 WEST' Investment and Partnering Conference, Feb....
Early-Stage Cardiovascular, Orthopedics/Spine, Ophthalmology, Imaging, and Regenerative Medicine Companies among the 50 Presenters at Medtech Insight...
Prominent Senior Executives from Stryker, St. Jude Medical, and Edwards Lifesciences Participating in Panel Discussion Titled 'The Big Company...
FINAL ANNOUNCEMENT: Medtech Insight and Windhover Information's 'Investment In Innovation (In3) WEST' Early-Stage Medical Technology Investment and...
Medtech Insight and Windhover Information's 2006 ``Investment in Innovation (In3) Europe: A Preview of Emerging Medical Technologies'' Premier...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles